Impact of Substance Use Disorder on ADHD and Its Treatment

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391 · see citing works

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616 · see citing works

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary

Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Himmelfarb, C. D., DePalma, S. M., Gidding, S. S., Jamerson, K., Jones, D. W., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.005 · Cited by 934 · see citing works

European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD

Kooij, S. J., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugué, M., Carpentier, P. J., Edvinsson, D., Fayyad, J., Foeken, K., Fitzgerald, M., et al. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-67 · Cited by 928 · see citing works

Linking neurodevelopmental and synaptic theories of mental illness through DISC1

Brandon, N. J., & Sawa, A. (2011) · Nature reviews. Neuroscience · doi:10.1038/nrn3120 · Cited by 422 · see citing works

Stigma and Treatment for Alcohol Disorders in the United States

Keyes, K. M., Hatzenbuehler, M. L., McLaughlin, K. A., Link, B. G., Olfson, M., Grant, B. F., & Hasin, D. S. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq304 · Cited by 436 · see citing works

Childhood Predictors of Adult Attention-Deficit/Hyperactivity Disorder: Results from the World Health Organization World Mental Health Survey Initiative

Lara, C., Fayyad, J., de Graaf, R., Kessler, R. C., Aguilar-Gaxiola, S., Angermeyer, M., Demytteneare, K., de Girolamo, G., Haro, J. M., Jin, R., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.005 · Cited by 420 · see citing works

Adult Outcomes of Childhood Dysregulation: A 14-year Follow-up Study

Althoff, R. R., Verhulst, F. C., Rettew, D. C., Hudziak, J. J., & van der Ende, J. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.08.006 · Cited by 303 · see citing works

Paliperidone for schizophrenia

Dolder, C. R., Nelson, M., & Deyo, Z. M. (2008) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp070261 · Cited by 254 · see citing works

Long-Term Efficacy and Safety of Iloperidone

Kane, J. M., Lauriello, J., LASKA, E. M., Marino, M. E. D., & Wolfgang, C. D. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318169cca7 · Cited by 250 · see citing works

Psychopharmacological Treatment for Very Young Children: Contexts and Guidelines

Gleason, M. M., EGGER, H. L., Emslie, G. J., Greenhill, L. L., Kowatch, R. A., Lieberman, A. F., Luby, J. L., Owens, J. A., Scahill, L. D., Scheeringa, M. S., et al. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181570d9e · Cited by 244 · see citing works

Antipsychotic-Induced Insulin Resistance and Postprandial Hormonal Dysregulation Independent of Weight Gain or Psychiatric Disease

Teff, K. L., Rickels, M. R., Grudziak, J., Fuller, C., Nguyen, H.-L., & Rickels, K. (2013) · Diabetes · doi:10.2337/db13-0430 · Cited by 195 · see citing works

Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients

van de Glind, G., van den Brink, W., Koeter, M. W. J., Carpentier, P.-J., van Emmerik-van Oortmerssen, K., Kaye, S., Skutle, A., Bu, E.-T. H., Franck, J., Konstenius, M., et al. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.04.010 · Cited by 189 · see citing works

The Psychopharmacology of Aggressive Behavior

Comai, S., Tau, M., & Gobbi, G. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31823f8770 · Cited by 132 · see citing works

The Psychopharmacology of Aggressive Behavior

Comai, S., Tau, M., Pavlovic, Z. M., & Gobbi, G. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31824929d6 · Cited by 120 · see citing works

Examining Critical Health Policy Issues within and beyond the Clinical Encounter: Patient-Provider Relationships and Help-seeking Behaviors

Boyer, C. A., & Lutfey, K. (2010) · Journal of Health and Social Behavior · doi:10.1177/0022146510383489 · Cited by 119 · see citing works

Adverse drug events associated with the use of analgesics, sedatives, and antipsychotics in the intensive care unit

Devlin, J. W., Corbett, S. M., & Riker, R. R. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181de125a · Cited by 110 · see citing works

Perceived Barriers to Treatment for Adolescent Depression

Meredith, L. S., Stein, B. D., Paddock, S. M., Jaycox, L. H., Quinn, V. P., Chandra, A., & Burnam, A. (2009) · Medical Care · doi:10.1097/mlr.0b013e318190d46b · Cited by 106 · see citing works

Increased Food Intake and Energy Expenditure Following Administration of Olanzapine to Healthy Men

Fountaine, R. J., Taylor, A. E., Mancuso, J. P., Greenway, F. L., Byerley, L. O., Smith, S. R., Most, M. M., & Fryburg, D. A. (2010) · Obesity · doi:10.1038/oby.2010.6 · Cited by 99 · see citing works

Psychological distress and risk of long-term disability: population-based longitudinal study

Rai, D., Kosidou, K., Lundberg, M., Araya, R., Lewis, G., & Magnusson, C. (2011) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2010.119644 · Cited by 99 · see citing works

Treatment seeking adults with autism or ADHD and co-morbid Substance Use Disorder: Prevalence, risk factors and functional disability

Sizoo, B. B., van den Brink, W., Koeter, M. W. J., Eenige, M. G.-V., van Wijngaarden-Cremers, P. J. M., & van der Gaag, R. J. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.09.003 · Cited by 99 · see citing works

Insulin Resistance and Decreased Glucose-Stimulated Insulin Secretion After Acute Olanzapine Administration

Chintoh, A. F., Mann, S. W., Lam, L., Lam, C., Cohn, T. A., Fletcher, P. J., Nóbrega, J. N., Giacca, A., & Remington, G. J. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318184b4c5 · Cited by 96 · see citing works

Medical Services for Clients in Community Mental Health Centers: Results From a National Survey

Druss, B. G., Marcus, S. C., Campbell, J., Cuffel, B., Harnett, J., Ingoglia, C., & Mauer, B. J. (2008) · Psychiatric Services · doi:10.1176/ps.2008.59.8.917 · Cited by 96 · see citing works

Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis

Fruyt, J. D., Deschepper, E., Audenaert, K., Constant, E., Floris, M., Pitchot, W., Sienaert, P. A., Souery, D., & Claes, S. J. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111408461 · Cited by 94 · see citing works

Evaluation of Universal Screening for Military-Related Sexual Trauma

Kimerling, R. E., Street, A. E., Gima, K. S., & Smith, M. W. (2008) · Psychiatric Services · doi:10.1176/appi.ps.59.6.635 · Cited by 95 · see citing works

Beyond Pharmacotherapy: Understanding the Links between Obesity and Chronic Mental Illness

Taylor, V. H., McIntyre, R. S., Remington, G. J., Levitan, R. D., Stonehocker, B., & Sharma, A. M. (2012) · The Canadian Journal of Psychiatry · doi:10.1177/070674371205700103 · Cited by 91 · see citing works

Personality Characteristics of Adults With Autism Spectrum Disorders or Attention Deficit Hyperactivity Disorder With and Without Substance Use Disorders

Sizoo, B. B., van den Brink, W., Eenige, M. G.-V., & van der Gaag, R. J. (2009) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e3181a61dd0 · Cited by 88 · see citing works

Relevance of interactions between dopamine and glutamate neurotransmission in schizophrenia

Buck, S. A., Erickson-Oberg, M. Q., Logan, R. W., & Freyberg, Z. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01649-w · Cited by 92 · see citing works

Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine

de Oliveira, L., Fraga, D. B., Luca, R. D. D., Canever, L., Ghedim, F. V., Matos, M. P. P., STRECK, E. L., Quevedo, J., & Zugno, A. I. (2011) · Metabolic Brain Disease · doi:10.1007/s11011-011-9234-1 · Cited by 88 · see citing works

Atypical Antipsychotics Rapidly and Inappropriately Switch Peripheral Fuel Utilization to Lipids, Impairing Metabolic Flexibility in Rodents

Albaugh, V. L., Vary, T. C., Ilkayeva, O., Wenner, B. R., Maresca, K. P., Joyal, J. L., Breazeale, S. D., Elich, T. D., Lang, C. H., & Lynch, C. J. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq053 · Cited by 86 · see citing works

Acute Effects of Single-Dose Olanzapine on Metabolic, Endocrine, and Inflammatory Markers in Healthy Controls

Hahn, M., Wolever, T., Arenovich, T., Teo, C., Giacca, A., Powell, V., Clarke, L., Fletcher, P. J., Cohn, T. A., McIntyre, R. S., et al. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31829e8333 · Cited by 83 · see citing works

Augmentation strategies for treatment-resistant depression

Carvalho, A., Machado, J. R., & Cavalcante, J. L. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32831be9ef · Cited by 74 · see citing works

Pharmacotherapy of Mood Disorders

Thase, M. E., & Denko, T. (2008) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.2.022305.095301 · Cited by 79 · see citing works

Incomplete response in late-life depression: getting to remission

Lenze, E. J., Sheffrin, M., Driscoll, H. C., Mulsant, B. H., Pollock, B. G., Dew, M. A., Lotrich, F., Devlin, B., Bies, R. R., & Reynolds, C. F. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.4/jlenze · Cited by 79 · see citing works

Pharmacogenetic Treatments for Drug Addiction: Cocaine, Amphetamine and Methamphetamine

Haile, C. N., Kosten, T. R., & Kosten, T. A. (2009) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990902825447 · Cited by 73 · see citing works

Pharmakologisches Neuroenhancement und „Hirndoping“

Franke, A., & Lieb, K. (2010) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-010-1105-0 · Cited by 64 · see citing works

Prevalence, symptom patterns and comorbidity of anxiety and depressive disorders in primary care in Qatar

Bener, A., Ghuloum, S., & Abou‐Saleh, M. T. (2011) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-011-0349-9 · Cited by 70 · see citing works

Medication Errors in Psychiatry

Procyshyn, R. M., Barr, A. M., Brickell, T. A., & Honer, W. G. (2010) · CNS Drugs · doi:10.2165/11533710-000000000-00000 · Cited by 65 · see citing works

Psychosocial treatment, antipsychotic postponement, and low‐dose medication strategies in first‐episode psychosis: A review of the literature

Bola, J. R., Lehtinen, K., Cullberg, J., & Ciompi, L. (2009) · Psychosis · doi:10.1080/17522430802610008 · Cited by 60 · see citing works

Correlates of alcohol use in adults with ADHD and comorbid alcohol use disorders: exploratory analysis of a placebo-controlled trial of atomoxetine

Wilens, T., Adler, L., Tanaka, Y., Xiao, F., D’Souza, D., Gutkin, S. W., & Upadhyaya, H. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.628648 · Cited by 59 · see citing works

Synthesis and Biological Evaluation of Fused Tricyclic Heterocycle Piperazine (Piperidine) Derivatives As Potential Multireceptor Atypical Antipsychotics

Cao, X., Zhang, Y., Chen, Y., Qiu, Y., Yu, M., Xu, X., Liu, X., Liu, B., Zhang, L., & Zhang, G. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01096 · Cited by 59 · see citing works

Ziprasidone Vs Olanzapine in Recent-Onset Schizophrenia and Schizoaffective Disorder: Results of an 8-Week Double-Blind Randomized Controlled Trial

Grootens, K. P., van Veelen, N. M. J., Peuskens, J., Sabbe, B., Thys, E., Buitelaar, J. K., Verkes, R. J., & Kahn, R. S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp037 · Cited by 57 · see citing works

Metabolomic profiling of schizophrenia patients at risk for metabolic syndrome

Paredes, R. M., Quinones, M. P., Marballi, K. K., Gao, X., Valdez, C., Ahuja, S. S., Velligan, D. I., & Walss‐Bass, C. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000157 · Cited by 57 · see citing works

A New Kind of Homelessness for Individuals With Serious Mental Illness? The Need for a "Mental Health Home"

Smith, T. E., & Sederer, L. I. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.4.528 · Cited by 56 · see citing works

Executive Summary: Evaluation and Management of Children and Adolescents With Acute Mental Health or Behavioral Problems. Part I: Common Clinical Challenges of Patients With Mental Health and/or Behavioral Emergencies

Chun, T. H., Mace, S. E., Katz, E. R., Shook, J. E., Conners, G. P., Conway, E. E., Dudley, N. C., Fuchs, S. M., Lane, N., Macias, C. G., et al. (2016) · PEDIATRICS · doi:10.1542/peds.2016-1571 · Cited by 55 · see citing works

Use of Primary and Specialized Mental Health Care for a Major Depressive Episode in Spain by ESEMeD Respondents

Gabilondo, A., Rojas‐Farreras, S., Rodráguez, A., Ferníndez, A., Pinto‐Meza, A., Vilagut, G., Haro, J. M., & Alonso, J. (2011) · Psychiatric Services · doi:10.1176/ps.62.2.pss6202_0152 · Cited by 52 · see citing works

Metabolic Syndrome: The Constellation of Co-morbidities, A Global Threat

Madan, K., Paliwal, S., Sharma, S. K., Kesar, S., Chauhan, N., & Madan, M. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230309144825 · Cited by 55 · see citing works

Shared Decision Making in Antipsychotic Management

Mistler, L. A., & Drake, R. E. (2008) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000341889.97759.54 · Cited by 48 · see citing works

MC4R rs489693: a clinical risk factor for second generation antipsychotic-related weight gain?

Czerwensky, F., Leucht, S., & Steimer, W. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000849 · Cited by 49 · see citing works

Schizophrenia endophenotypes as treatment targets

Thaker, G. K. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.9.1189 · Cited by 49 · see citing works

Co-occurring Mental Illness and Health Care Utilization and Expenditures in Adults with Obesity and Chronic Physical Illness

Shen, C., Sambamoorthi, U., & Rust, G. S. (2008) · Disease Management · doi:10.1089/dis.2007.0012 · Cited by 48 · see citing works

Attention‐ D eficit/ H yperactivity D isorder, P hysical H ealth, and L ifestyle in O lder A dults

Semeijn, E. J., Kooij, J. J. S., Comijs, H. C., Michielsen, M., Deeg, D. J. H., & Beekman, A. T. F. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12261 · Cited by 48 · see citing works

Personal Accounts of Discontinuing Neuroleptic Medication for Psychosis

Geyt, G. L., Awenat, Y. F., Tai, S., & Haddock, G. (2016) · Qualitative Health Research · doi:10.1177/1049732316634047 · Cited by 47 · see citing works

Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics

Krane‐Gartiser, K., Breum, L., Glümer, C., Linneberg, A. R., Madsen, M., Køster, A., Jepsen, P. W., & Fink‐Jensen, A. (2011) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2011.565799 · Cited by 45 · see citing works

Attention deficit hyperactivity disorder ( ADHD ) among illicit psychostimulant users: a hidden disorder?

Kaye, S. S., Darke, S. G., & Torok, M. H. (2012) · Addiction · doi:10.1111/add.12086 · Cited by 44 · see citing works

Adult Attention Deficit Hyperactivity Disorder and Violence in the Population of England: Does Comorbidity Matter?

González, R. A., Kallis, C., & Coid, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075575 · Cited by 38 · see citing works

Comparative Effectiveness of Atypical Antipsychotics in Schizophrenia

Attard, A., & Taylor, D. M. (2012) · CNS Drugs · doi:10.2165/11632020-000000000-00000 · Cited by 42 · see citing works

Tardive Dyskinesia and Tardive Dystonia With Second-Generation Antipsychotics in Non-Elderly Schizophrenic Patients Unexposed to First-Generation Antipsychotics

Ryu, S., Yoo, J. H., Kim, J. H., Choi, J. S., Baek, J. H., Ha, K., Kwon, J. S., & Hong, K. S. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000250 · Cited by 42 · see citing works

Modelling olanzapine-induced weight gain in rats

van der Zwaal, E. M., Janhunen, S. K., la Fleur, S. E., & Adan, R. A. H. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571300093x · Cited by 42 · see citing works

Metabolic Risk Factors Among Medicaid Outpatients With Schizophrenia Receiving Second-Generation Antipsychotics

Bell, R. C., Farmer, S., Ries, R. K., & Srebnik, D. S. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.12.1686 · Cited by 42 · see citing works

ADHD symptoms in non-treatment seeking young adults: relationship with other forms of impulsivity

Chamberlain, S. R., Ioannidis, K., Leppink, E. W., Niaz, F., Redden, S. A., & Grant, J. E. (2016) · CNS Spectrums · doi:10.1017/s1092852915000875 · Cited by 41 · see citing works

Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders

Gao, K., Sheehan, D. V., & Calabrese, J. R. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.37 · Cited by 41 · see citing works

Antioxidant Therapeutics for Schizophrenia

Reddy, R. D., & Reddy, R. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3571 · Cited by 40 · see citing works

Medication Adherence and the Use of Long-Acting Antipsychotics in Bipolar Disorder

El‐Mallakh, R. S. (2007) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000265764.87376.02 · Cited by 40 · see citing works

A Randomized, Placebo-Controlled Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain

McElroy, S. L., Winstanley, E. L., Mori, N. N., Martens, B. E., McCoy, J., Moeller, D., Guerdjikova, A. I., & Keck, P. E. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182488758 · Cited by 39 · see citing works

Risk behaviours among substance use disorder treatment seekers with and without adult ADHD symptoms

Kaye, S. S., Gilsenan, J., Young, J. T., CARRUTHERS, S. J., ALLSOP, S. J., Degenhardt, L. J., van de Glind, G., & van den Brink, W. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.008 · Cited by 39 · see citing works

Child and Caregiver Issues In the Treatment of Attention Deficit–Hyperactivity Disorder: Education, Adherence and Treatment Choice

Ferrín, M., & Taylor, E. A. (2011) · Future Neurology · doi:10.2217/fnl.11.5 · Cited by 39 · see citing works

The Role of Antipsychotics in Smoking and Smoking Cessation

Matthews, A. M., Wilson, V. B., & Mitchell, S. H. (2011) · CNS Drugs · doi:10.2165/11588170-000000000-00000 · Cited by 38 · see citing works

Obesity, cardiovascular disease and type 2 diabetes in people with a mental illness: a need for primary health care

Stanley, S. H., & Laugharne, J. D. E. (2011) · Australian Journal of Primary Health · doi:10.1071/py11045 · Cited by 38 · see citing works

Pharmacogenetics of Leptin in Antipsychotic-Associated Weight Gain and Obesity-Related Complications

Lee, A. K., & Bishop, J. R. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.45 · Cited by 38 · see citing works

Stimulant Formulation and Motivation for Nonmedical Use of Prescription Attention‐Deficit/Hyperactivity Disorder Medications in a College‐Aged Population

Upadhyaya, H. P., Kroutil, L. A., Deas, D., Durell, T. M., Brunt, D. L. V., & Novak, S. P. (2010) · American Journal on Addictions · doi:10.1111/j.1521-0391.2010.00078.x · Cited by 38 · see citing works

Symptom Prevalence of ADHD in a Community Residential Substance Abuse Treatment Program

McAweeney, M., Rogers, N. L., Huddleston, C., Moore, D., & Gentile, J. P. (2010) · Journal of Attention Disorders · doi:10.1177/1087054708329973 · Cited by 37 · see citing works

Effects of Controlled Discontinuation of Long-Term Used Antipsychotics on Weight and Metabolic Parameters in Individuals With Intellectual Disability

de Kuijper, G. M., Mulder, H., Evenhuis, H. M., Visser, F. E., & Hoekstra, P. J. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182905d6a · Cited by 37 · see citing works

Statistically Significant Increase in Weight Caused by Low‐Dose Quetiapine

Williams, S. G., Alinejad, N. A., Williams, J. A., & Cruess, D. F. (2010) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.10.1011 · Cited by 38 · see citing works

The 5-HT2 Receptor Profiles of Antipsychotics in the Pathogenesis of Obsessive-Compulsive Symptoms in Schizophrenia

Kim, S., Shin, I., Kim, J., Youn, T., Yang, S., Hwang, M. Y., & Yoon, J. (2009) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e318184fafd · Cited by 36 · see citing works

Prospective relationships of ADHD symptoms with developing substance use in a population-derived sample

Sihvola, E., Rose, R. J., Dick, D. M., Korhonen, T., Pulkkinen, L., Raevuori, A., MARTTUNEN, M. J., & Kaprio, J. A. (2011) · Psychological Medicine · doi:10.1017/s0033291711000791 · Cited by 34 · see citing works

All-Cause Mortality and Medication Risk Factors in Schizophrenia

Tenback, D. E., Pijl, B. J., Smeets, H. M., van Os, J., & van Harten, P. N. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31823f3c43 · Cited by 34 · see citing works

Childhood ADHD Symptoms Are Associated With Lifetime and Current Illicit Substance-Use Disorders and In-Site Health Risk Behaviors in a Representative Sample of Latino Prison Inmates

González, R. A., Vélez‐Pastrana, M. C., Varcárcel, J. J. R., LEVIN, F. R., & Albizu‐García, C. E. (2012) · Journal of Attention Disorders · doi:10.1177/1087054712461690 · Cited by 33 · see citing works

Undertreatment Before the Award of a Disability Pension for Mental Illness: The HUNT Study

Øverland, S. N., Glozier, N., Krokstad, S., & Mykletun, A. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.11.1479 · Cited by 33 · see citing works

Trajectories of ADHD severity over 10 years from childhood into adulthood

Tandon, M., Tillman, R., Arpana Agrawal, A., & Luby, J. L. (2016) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-016-0191-8 · Cited by 32 · see citing works

Inhibition of mouse brown adipocyte differentiation by second-generation antipsychotics

Oh, J.-E., Cho, Y. M., Kwak, S.-N., Kim, J. H., Lee, K., Jung, H., Jeong, S., & Kwon, O.-J. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.9.062 · Cited by 30 · see citing works

Adequacy of Antidepressant Treatment in Spanish Primary Care: A Naturalistic Six-Month Follow-Up Study

Pinto‐Meza, A., Fernández, A., Serrano‐Blanco, A., & Haro, J. M. (2008) · Psychiatric Services · doi:10.1176/ps.2008.59.1.78 · Cited by 29 · see citing works

Using Patient-facing Kiosks to Support Quality Improvement at Mental Health Clinics

Cohen, A. N., Chinman, M., Hamilton, A. B., Whelan, F., & Young, A. S. (2013) · Medical Care · doi:10.1097/mlr.0b013e31827da859 · Cited by 29 · see citing works

Adolescent Psychiatry

Merrick, J., & Sher, L. (2013) · De Gruyter eBooks · doi:10.1515/9783110316612 · Cited by 29 · see citing works

A Mutual Prodrug Ester of GABA and Perphenazine Exhibits Antischizophrenic Efficacy with Diminished Extrapyramidal Effects

Nudelman, A., Gil‐Ad, I., Shpaisman, N., Terasenko, I., Ron, H., Savitsky, K., Geffen, Y., Weizman, A., & Rephaeli, A. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7012453 · Cited by 29 · see citing works

Polymorphisms of INSIG2, MC4R, and LEP Are Associated With Obesity- and Metabolic-Related Traits in Schizophrenic Patients

Kuo, P., Kao, C., Chen, P., Chen, C.-H., Tsai, Y.-S., Lu, M., & Huang, M. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318234ee84 · Cited by 28 · see citing works

ADHD and Comorbid Disorders in Childhood Psychiatric Problems, Medical Problems, Learning Disorders and Developmental Coordination Disorder

Masi, L. (2015) · Clinical Psychiatry · doi:10.21767/2471-9854.100005 · Cited by 28 · see citing works

Prospective, Naturalistic, Pilot Study of Open-Label Atomoxetine Treatment in Preschool Children with Attention-Deficit/Hyperactivity Disorder

GHUMAN, J. K., Aman, M. G., Ghuman, H. S., Reichenbacher, T., Gelenberg, A. J., Wright, R., Rice, S. A., & Fort, C. L. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.054 · Cited by 27 · see citing works

Structure−Activity Relationships for a Novel Series of Dopamine D2-like Receptor Ligands Based on N-Substituted 3-Aryl-8-azabicyclo[3.2.1]octan-3-ol

Paul, N. M., Taylor, M., Kumar, R., Deschamps, J. R., Luedtke, R. R., & Newman, A. H. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800532x · Cited by 26 · see citing works

Detecting Mood Disorder in Resource-Limited Primary Care Settings: Comparison of a self-administered screening tool to general practitioner assessment

Vöhringer, P. A., Jimenez, M. I., Igor, M. A., Fores, G. A., Correa, M. O. S., Sullivan, M. C., Holtzman, N. S., Whitham, E. A., Barroilhet, S. A., Alvear, K., et al. (2013) · Journal of Medical Screening · doi:10.1177/0969141313503954 · Cited by 26 · see citing works

Waist Circumference is the Best Anthropometric Predictor for Insulin Resistance in Nondiabetic Patients with Schizophrenia Treated with Clozapine but not Olanzapine

Henderson, D. C., Fan, X., Sharma, B., Copeland, P. M., Borba, C. P. C., Freudenreich, O., Cather, C., Evins, A. E., & GOFF, D. C. (2009) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000358312.99233.ef · Cited by 26 · see citing works

Association of symptoms of attention deficit-hyperactivity disorder and impulsive-aggression with severity of suicidal behavior in adult attempters

Conejero, I., Jaussent, I., Lopez, R., Guillaume, S., Olié, É., Hebbache, C., Cohen, R. F., Kahn, J. P., Leboyer, M., Courtet, P., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41046-y · Cited by 25 · see citing works

Barriers to Metabolic Care for Adults with Serious Mental Illness: Provider Perspectives

McDonell, M. G., Kaufman, E. A., Srebnik, D. S., Ciechanowski, P. S., & Ries, R. K. (2011) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.41.4.g · Cited by 24 · see citing works

Inhibitory Control and Drug Abuse Prevention

Bardo, M., Fishbein, D., & Milich, R. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1268-8 · Cited by 12 · see citing works

A systematic review of metabolic side effects related to the use of antipsychotic drugs in dementia

Atti, A. R., Gozzi, B. F., Zuliani, G., Bernabei, V., Scudellari, P., Berardi, D., Ronchi, D. D., Tarricone, I., & Menchetti, M. (2013) · International Psychogeriatrics · doi:10.1017/s1041610213001658 · Cited by 22 · see citing works

The Clinical Utility of ASRS-v1.1 for Identifying ADHD in Alcoholics Using PRISM as the Reference Standard

Reyes, M. M., Schneekloth, T. D., Hitschfeld, M. J., Geske, J. R., Atkinson, D. L., & Karpyak, V. M. (2016) · Journal of Attention Disorders · doi:10.1177/1087054716646450 · Cited by 22 · see citing works

Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders

Icick, R., Moggi, F., Slobodin, O., Dom, G., Matthys, F., van den Brink, W., LEVIN, F. R., Blankers, M., Kaye, S. S., Demetrovics, Z., et al. (2020) · European Addiction Research · doi:10.1159/000508546 · Cited by 22 · see citing works

First-Episode Psychosis: A Window of Opportunity for Best Practices

Buckley, P. F., Correll, C. U., & Miller, A. L. (2007) · CNS Spectrums · doi:10.1017/s1092852900026213 · Cited by 22 · see citing works

A Sobering Fact: ADHD Leads to Substance Abuse

Wilens, T. E. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.10.002 · Cited by 22 · see citing works

Treatment of Co-Morbid Mental Illness in Primary Care: How to Minimize Weight Gain, Diabetes, and Metabolic Syndrome

Gibson, M. V., Carek, P. J., & Sullivan, B. (2011) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.41.2.c · Cited by 21 · see citing works

The nature of the relationship between attention-deficit/hyperactivity disorder and substance use.

Wilens, T. E. (2007) · PubMed · Cited by 110 · see citing works

When ADHD and substance use disorders intersect: Relationship and treatment implications

Wilens, T. E., & Fusillo, S. J. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0053-3 · Cited by 39 · see citing works

Treatment of Comorbid Substance Use Disorders and ADHD in Youth

Carrellas, N. W., Wilens, T., & Anselmo, R. (2016) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-016-0072-y · Cited by 6 · see citing works

The intersection of attention-deficit/hyperactivity disorder and substance abuse

Wilens, T. E., & Morrison, N. R. (2011) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328345c956 · Cited by 99 · see citing works

Attention-Deficit/Hyperactivity Disorder and Early-Onset Substance Use Disorders

Wilson, J. J., & Levin, F. R. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.751 · Cited by 71 · see citing works